| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 6+ Months |
| Number of Subjects | 50 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Average |
In sputum collected from the lungs of persons with COPD, ten months of supplementation (but not eight weeks) of 600mg N-acetylcysteine appeared to reduce the activation and adhesion of neutrophils to tissue, suggesting a mucolytic effect in the lungs.
